Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CDMO
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(928)
1 / 47
Chinese Biopharma
Pharmaceutical Innovation in China Takes Center Stage
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-17
Aug 25, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16
Aug 24, 2026
Supply Chain
Supply Chain Resilience in 2026: Any Progress?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-15
Aug 19, 2026
New Facilities
SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus
SK pharmteco
PR-08-26-02
Aug 18, 2026
AOCs
Antibody–Oligonucleotide Conjugates Clinical Manufacturing — A New Paradigm Shift of Bio-Conjugates for Therapeutics
Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.
GBI Biomanufacturing
PAO-08-26-CL-08
Aug 11, 2026
Supply Chain
Supply Chain Resilience Is Not an Insurance Cost, but Value Protection
Anurag Bhagania
OneSource Specialty Pharma
PAO-08-26-CL-07
Aug 6, 2026
Self-Injection
The Quiet Revolution in How We Take Our Medicine
Ravi Kumar
OneSource Specialty Pharma
PAO-08-26-CL-06
Aug 6, 2026
Innovation Partner
CDMOs as Innovation Partners in R&D
Prateek Gupta, Ph.D.
OneSource Specialty Pharma
PAO-08-26-CL-05
Aug 6, 2026
Cell Therapy
NueCell Bio Launches as a New Translational Partner to Accelerate Cell Therapies from Discovery into GMP Manufacturing
NueCell Bio
PR-08-26-01
Aug 5, 2026
Asia Manufacturing
The New Manufacturing Map of Asia
Pharma's Almanac
PAO-08-26-PA-03
Aug 5, 2026
Asia Manufacturing
APAC Expands Specialized Manufacturing Capabilities Across High-Value Modalities
Pharma's Almanac
PAO-08-26-PA-02
Aug 3, 2026
Geopolitics
How are geopolitical factors influencing sourcing and manufacturing decisions for 2026 and beyond?
Pharma's Almanac
PAO-07-26-RT-01
Jul 30, 2026
ADC Formulation
Controlling Complexity in ADC Formulation Development
Eunbi Iris Cho, Ph.D.
Samsung Biologics
PAO-07-26-CL-04
Jul 28, 2026
Combination Products
Collaboration is Key to Successful Injectable Drug–Device Combination Product Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-05
Jul 27, 2026
Liquids & Semisolids
What Makes a Great Liquid Oral Dose CDMO?
Rob Terry
TriRx Pharmaceutical Services
PAO-07-26-CL-01
Jul 22, 2026
LAI Formulation
The Formulation Science Behind Extended Drug Release
Pharma's Almanac
PAO-07-26-PA-03
Jul 9, 2026
Organoids
Data-Centric Organoid Services for Predictive Drug Response and Next-Generation Oncology Research
Seahee Kim, Ph.D.
Samsung Biologics
PAO-06-26-CL-04
Jul 1, 2026
Bioavailability
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
AustinPx
PR-06-26-03
Jun 30, 2026
Outsourcing
Do you expect continued movement away from one-stop-shop outsourcing toward deeper modality-specific expertise?
Pharma's Almanac
PAO-06-26-RT-01
Jun 29, 2026
Tech Transfer
Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success
Pharma's Almanac
PAO-06-26-PA-22
Jun 25, 2026
1 / 47